Sanger sequencing showed that MTC-22 cells harboured mutations in ARID1A (Q1346*) and PIK3CB (E1051K), both identical to those seen in the patient’s tumour tissue (Fig. 4d). This evidence concerns the gene PIK3CB and medullary thyroid gland carcinoma.